PSI Vaccine SIG Webinar 230: Developing COVID-19 vaccines

PSI Vaccine SIG Webinar 230: Developing COVID-19 vaccines
Traditional vaccine clinical development is an undertaking involving meticulous, multiple studies in multiple populations at risk of infection and disease over multiple years. SARS-CoV-2 and COVID-19 vaccine development is following this traditional development pathway, but accelerated Phase I-II-III clinical programs are being applied (c.f., USA FDA guidances 2020). This is not the first time vaccines have been manufactured and tested quickly to meet a public health crisis (1976, 2009). Selected statistical concepts pertaining to vaccine efficacy and safety, relevant during the design and implementation of such crisis programs, will be discussed.
12/10/2020 3:00 PM - 4:00 PM
All prices are in GBP.
If you are a PSI Non-Member and would like to register for an event, please use the link below to create an account. This is an account for events only and not a membership account.

Sign In